By Thomas J. Dougherty (Editor), Steven J. Projan (Editor)
Exploring leading edge routes of drug discovery within the postgenomic period, "Microbial Genomics and Drug Discovery" examines bioinformatic and genomic methods for the id, detection, choice, and validation of recent antibacterial goals and vaccine applicants. The publication discusses strength pathways for potent an infection regulate, inhibition of antibacterial resistance, and acceleration of the drug discovery procedure. This accomplished reference describes strategies to acknowledge universal goals in numerous bacterial species for the layout of broad-spectrum antibiotics and obviously illustrates using pathway instruments in a genomics-based drug discovery venture.
Read Online or Download Microbial Genomics and Drug Discovery PDF
Similar pharmacology books
In 1943, Albert Schatz, a tender Rutgers university Ph. D. scholar, labored on a wartime undertaking in microbiology professor Selman Waksman’s lab, trying to find an antibiotic to struggle infections at the entrance traces and at domestic. In his 11th scan on a typical bacterium present in farmyard soil, Schatz stumbled on streptomycin, the 1st potent treatment for tuberculosis, one of many world’s deadliest illnesses.
As director of Schatz’s examine, Waksman took credits for the invention, belittled Schatz’s paintings, and secretly enriched himself with royalties from the streptomycin patent filed via the pharmaceutical corporation Merck. In an remarkable lawsuit, younger Schatz sued Waksman, and was once presented the name of “co-discoverer” and a percentage of the royalties. yet years later, Professor Waksman by myself was once offered the Nobel Prize. Schatz disappeared into educational obscurity.
For the 1st time, acclaimed writer and journalist Peter Pringle unravels the intrigues at the back of some of the most vital discoveries within the historical past of medication. the tale unfolds on a tiny university campus in New Jersey, yet its repercussions unfold world wide. The streptomycin patent was once a step forward for the drug businesses, overturning patent limits on items of nature and paving the best way for today’s biotech global. As dozens extra antibiotics have been stumbled on, many from an analogous relations as streptomycin, the drug businesses created oligopolies and reaped massive gains. Pringle makes use of firsthand bills and data within the usa and Europe to bare the intensely human tale in the back of the invention that all started a revolution within the remedy of infectious ailments and formed the way forward for titanic Pharma.
The learn of G-quadruplexes has emerged in recent times as an immense concentration of analysis in nucleic acids. this can be now a speedily growing to be sector, no longer least as a result of its capability as a singular method of melanoma therapeutics, and there's a lot present task at the layout of quadruplex-selective small-molecule ligands and the research in their mobile results.
This definitive resource booklet on psychoactive medications . . . offers elementary discussions of every substance's nature, the way it is probably going to impact the physique, and what precautions are essential to restrict any capability for damage. broadly illustrated with pictures and line drawings.
- Let Thy Food Be Thy Medicine: Plants and Modern Medicine
- Toxicological profiles - Ammonia
- Functional Informatics in Drug Discovery
- Introduction to Neuropharmacology
- The Pharmacology of Psychotherapeutic Drugs
- Effective Drug Regulation: A Multicountry Study
Extra resources for Microbial Genomics and Drug Discovery
Alternatively, surfaceassociated antigens can be selected experimentally by cellular fractionation of the bacteria into cell wall proteins and subsequent characterization of these proteins by two-dimensional gel electrophoresis and mass spectrometry. Genes encoding proteins identified by either approach can then be cloned into expression vectors for subsequent expression and purification of each protein and further determination of its suitability as an antigen. The in silico approach was used by Pizza and co-workers  to identify 600 surface-associated proteins from the genome of serogroup B Meningococcus.
Microbiol 4:65–70, 2001. 38. F Arigoni, F Talabot, M Peitsch, MD Edgerton, E Meldrum, E Allet, R Fish, T Jamotte, ML Curchod, H Loferer. Nat. Biotechnol 16:851–856, 1998. 39. SL Chiang, JJ Mekalanos, DW Holden. Annu. Rev. Microbiol 53:129–154, 1999. 40. J Horecka, Y Jigami. Yeast 16:967–970, 2000. 41. S Fields, O Song. Nature 340:245–246, 1989. 42. PL Bartel, JA Roecklein, D SenGupta, S Fields. Nature Genet. 12:72–77, 1996. 43. P Uetz, L Giot, G Cagney, TA Mansfield, RS Judson, JR Knight, D Lockshon, V Narayan, M Srinivasan, P Pochart, A Qureshi-Emili, Y Li, B Godwin, D Conover, T Kalbfleisch, G Vijayadamodar, M Yang, M Johnston, S Fields, JM Rothberg.
Upon this foundation, many associated techniques have been developed or improved, such as microarraying, proteomics, and other laboratory and bioinformatic techniques. All of these “genomics technologies” have one aspect in common: the ability to analyze gene function in a high-throughput manner. Antimicrobial drug discovery was one of the first areas to benefit from genomics, due to relatively small genome sizes and, in many cases, systems amenable to genetic manipulation. This chapter describes how bioinformatic and genomic technologies are being leveraged for the discovery of novel antimicrobials.